Open house drug rebate contracts Botulinum toxin type A, finished pharmaceutical product name Xeomin(R), ATC M03AX21
Open house Arzneimittelrabattverträge Botulinumtoxin Typ A, Fertigarzneimittelbezeichnung Xeomin(R), ATC M03AX21
Germany
Contract
BuyerAOK Bayern - Die Gesundheitskasse
TypeSupplies
Estimated valuevalue not published
Published17 January 2025
CategoryMedical equipment & pharma · CPV 33000000
Who has won here before
| Company | Awards | Period |
|---|---|---|
| ratiopharm GmbH | 56 | 2014–2023 |
| Hexal AG · Holzkirchen | 46 | 2011–2022 |
| Aliud Pharma GmbH · Laichingen | 45 | 2011–2023 |
| Haemato Pharm GmbH · Schönefeld | 43 | 2014–2022 |
| Orifarm GmbH · Leverkusen | 39 | 2018–2023 |
From 13.7M documented awards · regular winners know this buyer's requirements — that is your competition.
How often this buyer tenders this
2019269
2020363
2021221
2022268
2023319
2024467
20254
2025704
2026392
Who knows the rhythm prepares instead of reacting.
138
days until the deadline — Tuesday 5 January at 10:00
How to bid
Read the full notice — Original + documents
Goes directly to this tender on Vergabemarktplatz (cosinex). The full specification and all annexes are there.
Tenders like this, every morning at 7:30 in your inbox.
Start free →